Elixinol Wellness Limited reported a 12.8% increase in revenue to $7.6 million for the first half of 2025, driven by Healthy Chef and Hemp Foods Australia, alongside improved gross margins. However, integration expenses weighed on profitability, resulting in an adjusted EBITDA loss of $2.2 million.
H&S Group has exercised performance options to increase its stake in Nuchev Limited to 48.62%, injecting $1.9 million and enhancing Nuchev’s financial flexibility for growth.
Nuchev Limited reported a remarkable 215% increase in quarterly revenue, driven by the strategic launch of Oli6® in Vietnam and the acquisition of bWellness, signaling robust expansion across key Asia-Pacific markets.
Nuchev Limited has appointed Nathan Cheong as its new CEO, with current CEO Mick Myers transitioning to COO and CFO roles, signaling a strategic leadership evolution.